ConductScience.org, home
A Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in Late-onset GM2
API referenceFor AI assistants

Trial · NCT04221451

Participant flow36

How many started, completed or left each group, period by period.

1 to 20 of 36

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
PAP: Baseline (Day 1) up to 104 WeeksSTARTEDPAP: PP: Placebo19
PAP: Baseline (Day 1) up to 104 WeeksSTARTEDPAP: PP: Venglustat40
PAP: Baseline (Day 1) up to 104 WeeksSTARTEDPAP: SP: Venglustat16
PAP: Baseline (Day 1) up to 104 WeeksSTARTEDOLE: PP: Delayed Venglustat0
PAP: Baseline (Day 1) up to 104 WeeksSTARTEDOLE: PP: Early Venglustat0
PAP: Baseline (Day 1) up to 104 WeeksSTARTEDOLE: SP: Venglustat0
PAP: Baseline (Day 1) up to 104 WeeksCOMPLETEDPAP: PP: Placebo17
PAP: Baseline (Day 1) up to 104 WeeksCOMPLETEDPAP: PP: Venglustat35
PAP: Baseline (Day 1) up to 104 WeeksCOMPLETEDPAP: SP: Venglustat14
PAP: Baseline (Day 1) up to 104 WeeksCOMPLETEDOLE: PP: Delayed Venglustat0
PAP: Baseline (Day 1) up to 104 WeeksCOMPLETEDOLE: PP: Early Venglustat0
PAP: Baseline (Day 1) up to 104 WeeksCOMPLETEDOLE: SP: Venglustat0
PAP: Baseline (Day 1) up to 104 WeeksNOT COMPLETEDPAP: PP: Placebo2
PAP: Baseline (Day 1) up to 104 WeeksNOT COMPLETEDPAP: PP: Venglustat5
PAP: Baseline (Day 1) up to 104 WeeksNOT COMPLETEDPAP: SP: Venglustat2
PAP: Baseline (Day 1) up to 104 WeeksNOT COMPLETEDOLE: PP: Delayed Venglustat0
PAP: Baseline (Day 1) up to 104 WeeksNOT COMPLETEDOLE: PP: Early Venglustat0
PAP: Baseline (Day 1) up to 104 WeeksNOT COMPLETEDOLE: SP: Venglustat0
OLE (104 Weeks): From 104 to 208 WeeksSTARTEDPAP: PP: Placebo0
OLE (104 Weeks): From 104 to 208 WeeksSTARTEDPAP: PP: Venglustat0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04221451/flow

API referenceFor AI assistants